Analytical aspects of the automated CKMB1,2 and CKMM1,2,3 isoform determination and its relation to other biochemical markers

REFERENCES

• Neumeier D. Tissue specific and subcellular distri-bution of creatine kinase isoenzymes. In: Lang H, editor. Creatine kinase isoenzymes. Berlin/Heidel-berg: Springer-Verlag, 1981: 85–131.
   Google Scholar
• Wevers RA, Olthuis HP, Van Niel JCC, Van Wil-genberg MG, Soons JB. A study on the dimeric structure of creatine kinase. Clin Chim Acta 1977; 75: 377–85.
   PubMed Web of Science ®Google Scholar
• George S, Ishikawa Y, Perryman MB, Roberts R. Purification and characterization of naturally occurring and in vitro induced forms of MM crea-tine kinase. J Biol Chem 1984; 259: 2667–74.
   PubMedGoogle Scholar
• Prager NP, Suzuki T, Jaffe AS, Sobel BE, Abendschein DR. Nature and time course of gen-eration of isoforms of MB creatine kinase in vivo. J Am Coll Cardiol 1992; 20: 414–19.
   Google Scholar
• Morelli R1, Carlson CJ, Emilson B, Abendschein DR, Rapaport E. Serum creatine kinase MM iso-enzyme sub-bands after AMI in man. Circulation 1983; 67: 1283–9.
   Google Scholar
• Jaffe AS, Serota H, Grace A, Sobel BE. Diagnostic changes in plasma creatine kinase isoforms early after the onset of AMI. Circulation 1986; 74: 105–9.
   PubMedGoogle Scholar
• Apple FS. AMI and coronary reperfusion. Am J Clin Pathol 1992; 97: 217–26.
   PubMedGoogle Scholar
• Roberts R. Diagnostic assessment of myocardial infarction based on lactate dehydrogenase and creatine kinase isoenzymes. Heart Lung 1981; 10: 486–506.
   PubMedGoogle Scholar
• Grande P, Christiansen C, Pedersen A, Christen-sen MS. Optimal diagnosis in AMI: a cost-effec-tiveness study. Circulation 1980; 61: 723–8.
   Google Scholar
• Robert R. Myoglobinemia as an index to myocar-dial infarction. Ann Intern Med 1977; 87: 788–9.
   PubMedGoogle Scholar
• Mair J, Artner-Dworzak E, Lechleitner P, et al. Early diagnosis of AMI by a newly developed rapid immunoturbidimetric assay for myoglobin. Br Heart J 1992; 68: 462–8.
   PubMedGoogle Scholar
• Katus HA, Remppis A, Looser S, Hallermeier K, Sheffold T, Kuebler W. Enzyme linked immuno-assay of cardiac troponin T for the detection of AMI in patients. J Moll Cell Cardiol 1989; 21: 1349–53.
   PubMed Web of Science ®Google Scholar
• Collinson PO, Moseley D, Stubbs PJ, Carter GD. Troponin T for the differential diagnosis of ischae-mic myocardial damage. Ann Clin Biochem 1993; 30: 11–16.
   PubMed Web of Science ®Google Scholar
• Cummins B, Auckland M, Cummins P. Cardiac-specific troponin-I radioimmunoassay in the diag-nosis of AMI. Am Heart J 1987; 113: 1333–44.
   Google Scholar
• Bodor GS, Porter S, Landt Y, Ladenson JH. The development of monoclonal antibodies and an assay for cardiac troponin-I with preliminary results in suspected myocardial infarction. Clin Chem 1992; 11: 2203–14.
   Google Scholar
• Tanaka T, Hirota Y, Sohmiya K-I, Nishimura S, Kawamura K. Serum and urinary human heart fatty acid binding protein in AMI. Clin Biochem 1991; 24: 195–201.
   Google Scholar
• Rabitzsch G, Mair J, Lechleitner P, etal. Immuno-enzymometric assay of human Glycogen Phos- phorylase Isoenzyme BB in diagnosis of ischemic myocardial injury. Clin Chem 1995; 41: 966–78.
   PubMed Web of Science ®Google Scholar
• Puleo PR, Meyer D, Wathen C, etal. Use of a rapid assay of subforms of creatine kinase MB to diag-nose or rule out AMI. N Engl J Med 1994; 331: 561–6.
   PubMed Web of Science ®Google Scholar
• Panteghini M, Cuccia C, Malchiodi A. Isoforms of creatine kinase MM and MB in AMI: a clinical evaluation. Clin Chim Acta 1986; 155: 1–10.
   PubMedGoogle Scholar
• Working Group on the establishment of ischaemic heart disease registers. Report of the Fifth Work-ing Group 8201 (5). Copenhagen: WH01971
   Google Scholar
• Swaanenburg JCJM, Pentinga M, DeJongste MJH, et al. Implications of automated creatine kinase (CK)-MM1,2,3 /CK-MB1,2 isoform analy-sis as an early marker for the detection of myocar-dial tissue damage. Scand J Clin Lab Invest 1996; 56: 627–33.
   PubMedGoogle Scholar
• Patterson W, Werness P, Payne J, et al. Random and continuous-access immunoassays with chemi-luminescent detection by Access automated analy-zer. Clin Chem 1994; 40: 2042–5.
   PubMedGoogle Scholar
• Weiland J, Poppy U, Drosdat H, Heubner A, Kaehler H. Evaluation of the enzyme immuno-assays PSA, CEA, and AFP on the fully automated analytical system MAGIA 7000. Klin Lab 1994; 40: 1249–53.
   Google Scholar
• Hoyle NR, Eckert B, Krais S. Electrochemilumi-nescence: leading-edge technology for automated immunoassay analyte detection. Clin Chem 1996; 42: 1576–8.
   Google Scholar
• Wu AHB, Wang XM, Gornet TG, et al. Creatine kinase MB isoforms in patients with skeletal mus-cle injury: ramifications for early detection of AMI. Clin Chem 1992; 38: 2396–400.
   PubMed Web of Science ®Google Scholar
• Laurino JP, Bender EW, Kessimian N, etal. Com-parative sensitivities and specificities of the mass measurements of CK-MB2, CK-MB, and myoglo-bin for diagnosing AMI. Clin Chem 1996; 42: 1454–9.
   PubMedGoogle Scholar
• Hetland 0, Dickstein K. Cardiac markers in the early hours of AMI: clinical performance of crea-tine kinase, creatine kinase MB isoenzyme (activ-ity and mass concentration), creatine kinase MM and MB subform ratios, myoglobin and cardiac troponin T. Scan J Clin Lab Invest 1996; 56: 701–13.
   Google Scholar
• Roberts R, Kleiman NS. Earlier diagnosis and treatment of AMI necessitates the need for a "new diagnostic mind-set". Circulation 1994; 89: 872–81.
   PubMed Web of Science ®Google Scholar
• Sturk A, Sanders GTB. Macro enzymes: preva-lence, composition, detection and clinical rele-vance. J Clin Chem Clin Biochem 1990; 28: 65–81.
   PubMedGoogle Scholar
• Murthy VV. Identification of false-positive CK-MB activity in an elderly patient. Am J Clin Pathol 1993; 99: 97–100.
   PubMedGoogle Scholar
• Clark GL, Robinson AK, Roberts R, Sobel BE. Effects of lymphatic transport of enzyme on plasma creatine kinase time activity curves after myocardial infarction in dogs. Circ Res 1978; 43: 162–9.
   PubMed Web of Science ®Google Scholar